Close Menu

NEW YORK (GenomeWeb) – Vela Diagnostics said that the China Food and Drug Administration has approved its Sentosa SX Cell-free DNA Kit.

The kit is designed to extract cell-free circulating DNA from plasma and is developed for use in real-time PCR and next-generation sequencing workflows. It runs on Vela's Sentosa SX101 instrument, an automated liquid handling system for DNA extraction.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Sponsored by

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.